These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9033847)

  • 41. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis C. The surprise infectious disease of the decade.
    Mayo Clin Health Lett; 1998 Feb; 16(2):6. PubMed ID: 9516363
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cryoglobulinemia and hepatitis C virus].
    Bessone F
    Gastroenterol Hepatol; 1997 Apr; 20(4):193-5. PubMed ID: 9280615
    [No Abstract]   [Full Text] [Related]  

  • 44. [Is the treatment of chronic viral hepatitis C with interferon-alpha effective?].
    Beker S; Pujol FH; Beker B
    G E N; 1995; 49(2):165-9. PubMed ID: 8566691
    [No Abstract]   [Full Text] [Related]  

  • 45. Interferon treatment of children with chronic hepatitis C.
    al-Tawil Y; Nelson C
    Hepatogastroenterology; 1998; 45(20):345-8. PubMed ID: 9638404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Epidermolysis bullosa acquisita and hepatitis C].
    Thiery S; Misery L; Chossegros P; Kanitakis J; Ghohestani R; Forestier JY; Trepo C; Faure M; Claudy A
    Ann Dermatol Venereol; 1998 Apr; 125(4):264-7. PubMed ID: 9747265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
    Umemura T; Alter HJ; Tanaka E; Orii K; Yeo AE; Shih JW; Matsumoto A; Yoshizawa K; Kiyosawa K
    Hepatology; 2002 Apr; 35(4):953-9. PubMed ID: 11915044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Interferon-alpha in the treatment of chronic viral hepatitis].
    Melman ML
    Rev Gastroenterol Mex; 1994; 59(2 Suppl):46-8. PubMed ID: 8091094
    [No Abstract]   [Full Text] [Related]  

  • 49. Hepatitis C: changing genotype distribution with important implications for patient management.
    van Soest H; Boland GJ; van Erpecum KJ
    Neth J Med; 2006 Apr; 64(4):96-9. PubMed ID: 16609154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pegylated interferon-alpha for the treatment of chronic hepatitis C].
    Weis NM; Krarup HB; Skinhøj P
    Ugeskr Laeger; 2003 Oct; 165(44):4211-5. PubMed ID: 14621552
    [No Abstract]   [Full Text] [Related]  

  • 51. [Serum smooth muscle antibodies with anti-actin specificity appeared during treatment with interferon alpha].
    Grimbert S; Mohib S; Johannet C; Trinchet JC; Beaugrand M
    Gastroenterol Clin Biol; 1996; 20(4):404-5. PubMed ID: 8758511
    [No Abstract]   [Full Text] [Related]  

  • 52. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [When should the treatment with interferon alpha be discontinued in chronic hepatitis C?].
    Castilla Cortázar A
    Med Clin (Barc); 1993 Dec; 101(20):774-6. PubMed ID: 8114538
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical outcome to interferon therapy in chronic hepatitis C: insights from mechanistic studies.
    Beard MR
    Antivir Ther; 2004 Oct; 9(5):637-9. PubMed ID: 15535401
    [No Abstract]   [Full Text] [Related]  

  • 55. Therapy of hepatitis C: alpha interferon and ribavirin.
    Reichard O; Schvarcz R; Weiland O
    Hepatology; 1997 Sep; 26(3 Suppl 1):108S-111S. PubMed ID: 9305674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of chronic hepatitis C.
    Nelson DR; Davis GL
    Compr Ther; 1997 Apr; 23(4):269-76. PubMed ID: 9167919
    [No Abstract]   [Full Text] [Related]  

  • 57. Anaesthesia for a patient on interferon therapy.
    Coleman M; Traynor C
    Acta Anaesthesiol Scand; 1999 Jan; 43(1):115-6. PubMed ID: 9926203
    [No Abstract]   [Full Text] [Related]  

  • 58. Lack of sustained efficacy of interferon in patients with chronic hepatitis C.
    Vento S; Concia E; Ferraro T
    N Engl J Med; 1996 May; 334(22):1479-80. PubMed ID: 8618600
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapy of hepatitis C: overview.
    Lindsay KL
    Hepatology; 1997 Sep; 26(3 Suppl 1):71S-77S. PubMed ID: 9305668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Side effects of alpha interferon in chronic hepatitis C.
    Dusheiko G
    Hepatology; 1997 Sep; 26(3 Suppl 1):112S-121S. PubMed ID: 9305675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.